What is the Themis Medicare Ltd share price today?

The share price of NSE:THEMISMED-EQ on 01 Oct 2026 (as of 15:05:05 IST) is ₹113.52.

What is the NSE:THEMISMED-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:THEMISMED-EQ 52 week high low range shows a high of ₹147 and a low of ₹64.95.

What is the Themis Medicare Ltd market cap?

As on 01 Oct 2026, Themis Medicare Ltd market cap is ₹10771100000.

What is the shareholding pattern of Themis Medicare Ltd Stock?

The shareholding pattern of Themis Medicare Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 67.11% Foreign Institutional Investors (FII): 0.01% Domestic Institutional Investors (DII): 0.01% Mutual Funds: 0% Retail & Others: 32.87% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Themis Medicare Ltd?

The Price-to-Earnings (PE) ratio of Themis Medicare Ltd is 26.9453, and the Price-to-Book (PB) ratio is 1.522, as on 01 Oct 2026.

Themis Medicare Share Price

100.70+0.97 (+0.97%)

-19.51% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.97%

1 Week

+6.19%

1 Month

-10.80%

3 Month

-10.71%

6 Month

+3.29%

YTD

+0.10%

1 Year

-19.51%

5 Year

+7.37%

10 Year

+55.02%

Max

+611.66%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

98.41

95.05

88.86

64.95

High

103.00

117.98

140.60

About

Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management Critical Care and Anti-Infectives. The company develops Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

THEMISMEDNSE

LTP

1W Low

1W High

Market cap (₹)

1804.1+26.4 (1.49%)

1722

1810.40

4,25,150Cr

9988.5+208.5 (2.13%)

9863

10067

2,66,265Cr

4677.4+64 (1.39%)

4553

4685.60

1,76,301Cr

2334.7-70.8 (-2.94%)

2252.40

2441.90

1,25,352Cr

1261.3+15.8 (1.27%)

1217.20

1264.50

1,23,591Cr

1368.4+16.4 (1.21%)

1336.70

1376.70

1,14,351Cr

1395+16.1 (1.17%)

1364.60

1400.80

1,12,474Cr

2498.8+6 (0.24%)

2457.90

2512.30

1,02,315Cr

1701.6+20.2 (1.20%)

1656.20

1708.80

97,757Cr

2038.2+27.2 (1.35%)

1988.90

2062.10

92,007Cr

100.7+5.87 (6.19%)

95.05

103

914Cr

Themis Medicare Share Price

100.70+0.97 (+0.97%)

-19.51% past 1 Year

Financial overview

Compounded Sales Growth

10 years4%

5 years8%

3 years-1%

Last year-16%

Compounded Profit Growth

10 years-23%

5 years-50%

3 years-73%

Last year-96%

Stock Price CAGR

10 years4%

5 years1%

3 years-14%

1 year-20%

Return on Equity

10 years11%

5 years13%

3 years7%

Last year0%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
4%	8%	-1%	-16%
-23%	-50%	-73%	-96%
4%	1%	-14%	-20%
11%	13%	7%	0%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

THEMISMED

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,804.1	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
9,988.5	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,677.4	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,334.7	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,261.3	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,368.4	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,395	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,498.8	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,701.6	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,038.2	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
100.7	₹914 Cr	22.86	2.67	5.46	₹1 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014
₹87 Cr	₹77 Cr	₹90 Cr	₹78 Cr	₹98 Cr	₹72 Cr	₹94 Cr	₹117 Cr	₹123 Cr	₹98 Cr	₹83 Cr	₹105 Cr	₹97 Cr	₹80 Cr	₹89 Cr	₹91 Cr	₹94 Cr	₹80 Cr	₹95 Cr	₹107 Cr	₹113 Cr	₹62 Cr	₹66 Cr	₹55 Cr	₹48 Cr	₹46 Cr	₹54 Cr	₹50 Cr	₹51 Cr	₹36 Cr	₹48 Cr	₹49 Cr	₹50 Cr	₹52 Cr	₹50 Cr	₹62 Cr	₹47 Cr	₹52 Cr	₹63 Cr	₹59 Cr	₹67 Cr	₹54 Cr	₹56 Cr	₹64 Cr	₹60 Cr	₹50 Cr	₹50 Cr	₹43 Cr	₹59 Cr
₹99 L	₹4 Cr	₹1 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹96 L	₹1 Cr	₹57 L	₹2 Cr	₹65 L	₹3 Cr	₹6 Cr	₹2 Cr	₹69 L	₹2 Cr	₹4 Cr	₹21 L	₹35 L	₹88 L	₹25 L	₹2 Cr	₹36 L	₹38 L	₹3 Cr	₹8 L	₹9 L	₹2 Cr	₹19 L	₹2 Cr	₹30 L	₹74 L	₹34 L	₹2 Cr	₹27 L	₹32 L	₹19 L	₹59 L	₹2 Cr	₹47 L	₹66 L	₹14 L	₹2 Cr	₹78 L	₹11 Cr	₹9 L	₹86 L
₹88 Cr	₹80 Cr	₹91 Cr	₹81 Cr	₹99 Cr	₹73 Cr	₹95 Cr	₹118 Cr	₹124 Cr	₹99 Cr	₹83 Cr	₹107 Cr	₹97 Cr	₹83 Cr	₹95 Cr	₹93 Cr	₹95 Cr	₹82 Cr	₹99 Cr	₹108 Cr	₹113 Cr	₹63 Cr	₹66 Cr	₹57 Cr	₹49 Cr	₹47 Cr	₹57 Cr	₹50 Cr	₹51 Cr	₹37 Cr	₹48 Cr	₹51 Cr	₹51 Cr	₹53 Cr	₹50 Cr	₹64 Cr	₹48 Cr	₹52 Cr	₹63 Cr	₹60 Cr	₹69 Cr	₹54 Cr	₹56 Cr	₹64 Cr	₹61 Cr	₹50 Cr	₹61 Cr	₹43 Cr	₹60 Cr
₹142 Cr	₹75 Cr	₹83 Cr	₹84 Cr	₹110 Cr	₹80 Cr	₹88 Cr	₹102 Cr	₹96 Cr	₹92 Cr	₹78 Cr	₹95 Cr	₹78 Cr	₹72 Cr	₹76 Cr	₹72 Cr	₹77 Cr	₹68 Cr	₹80 Cr	₹86 Cr	₹74 Cr	₹52 Cr	₹52 Cr	₹47 Cr	₹38 Cr	₹35 Cr	₹47 Cr	₹47 Cr	₹46 Cr	₹44 Cr	₹48 Cr	₹49 Cr	₹48 Cr	₹45 Cr	₹47 Cr	₹54 Cr	₹49 Cr	₹44 Cr	₹57 Cr	₹58 Cr	₹59 Cr	₹48 Cr	₹49 Cr	₹54 Cr	₹53 Cr	₹46 Cr	₹55 Cr	₹40 Cr	₹53 Cr
-₹51 Cr	₹7 Cr	₹11 Cr	₹15 L	-₹9 Cr	-₹4 Cr	₹10 Cr	₹18 Cr	₹30 Cr	₹10 Cr	₹9 Cr	₹15 Cr	₹22 Cr	₹13 Cr	₹21 Cr	₹23 Cr	₹21 Cr	₹16 Cr	₹21 Cr	₹24 Cr	₹41 Cr	₹13 Cr	₹15 Cr	₹12 Cr	₹13 Cr	₹14 Cr	₹12 Cr	₹6 Cr	₹8 Cr	-₹4 Cr	₹2 Cr	₹5 Cr	₹4 Cr	₹10 Cr	₹6 Cr	₹11 Cr	₹88 L	₹10 Cr	₹7 Cr	₹4 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹12 Cr	₹11 Cr	₹8 Cr	₹9 Cr	₹6 Cr	₹9 Cr
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr
₹36 Cr	₹2 Cr	₹5 Cr	-₹5 Cr	-₹14 Cr	-₹9 Cr	₹4 Cr	₹13 Cr	₹25 Cr	₹5 Cr	₹3 Cr	₹10 Cr	₹17 Cr	₹8 Cr	₹16 Cr	₹18 Cr	₹16 Cr	₹12 Cr	₹17 Cr	₹19 Cr	₹36 Cr	₹8 Cr	₹10 Cr	₹6 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹14 L	₹2 Cr	-₹9 Cr	-₹4 Cr	-₹4 L	-₹35 L	₹6 Cr	₹1 Cr	₹6 Cr	-₹4 Cr	₹5 Cr	₹3 Cr	-₹64 L	₹7 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹1 Cr	₹2 Cr	-₹93 L	₹3 Cr
₹22 Cr	₹2 Cr	₹5 Cr	-₹5 Cr	-₹14 Cr	-₹8 Cr	₹3 Cr	₹10 Cr	₹19 Cr	₹3 Cr	₹2 Cr	₹7 Cr	₹13 Cr	₹6 Cr	₹12 Cr	₹14 Cr	₹12 Cr	₹8 Cr	₹12 Cr	₹15 Cr	₹27 Cr	₹6 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹8 Cr	₹63 L	₹3 Cr	-₹9 Cr	-₹2 Cr	₹29 L	-₹4 L	₹5 Cr	₹1 Cr	₹6 Cr	-₹4 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹7 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹6 Cr	-₹66 L	₹2 Cr	-₹93 L	₹4 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr
₹0	₹0	₹0	₹7 L	₹24 L	₹37 L	₹49 L	₹60 L	₹54 L	₹2 Cr	₹0	₹0	₹0	₹85 L	₹0	₹0	₹0	₹0	₹0	₹0
₹389 Cr	₹393 Cr	₹368 Cr	₹330 Cr	₹278 Cr	₹209 Cr	₹173 Cr	₹148 Cr	₹159 Cr	₹141 Cr	₹66 Cr	₹51 Cr	₹48 Cr	₹43 Cr	₹50 Cr	₹84 Cr	₹76 Cr	₹84 Cr	₹77 Cr	₹61 Cr
₹389 Cr	₹393 Cr	₹368 Cr	₹330 Cr	₹278 Cr	₹209 Cr	₹173 Cr	₹148 Cr	₹159 Cr	₹141 Cr	₹66 Cr	₹51 Cr	₹48 Cr	₹43 Cr	₹50 Cr	₹84 Cr	₹76 Cr	₹59 Cr	₹76 Cr	₹61 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹25 Cr	₹47 L	₹48 L
₹399 Cr	₹403 Cr	₹378 Cr	₹339 Cr	₹287 Cr	₹219 Cr	₹183 Cr	₹158 Cr	₹169 Cr	₹152 Cr	₹74 Cr	₹59 Cr	₹57 Cr	₹52 Cr	₹59 Cr	₹92 Cr	₹84 Cr	₹92 Cr	₹85 Cr	₹69 Cr
-₹16,000	-₹14,000	-₹12,000	-₹9,000	-₹7,000	-₹6,000	-₹5,000	-₹2 L	-₹6 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹20 Cr	₹16 Cr	₹21 Cr	₹19 Cr	₹11 Cr	₹6 Cr	₹9 L	₹14 L	₹1 L	₹47 L	₹16 Cr	₹19 Cr	₹24 Cr	₹32 Cr	₹3 Cr	₹6 L	₹60 Cr	₹60 Cr	₹60 Cr	₹43 Cr
₹2 Cr	₹2 Cr	₹6 Cr	₹10 Cr	₹13 Cr	₹16 Cr	₹12 Cr	₹9 Cr	₹11 Cr	₹12 Cr	₹48 Cr	₹56 Cr	₹52 Cr	₹60 Cr	₹62 Cr	₹61 Cr	₹64 Cr	₹66 Cr	₹53 Cr	₹41 Cr
₹9 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹95 L	-₹5 Cr	-₹7 Cr	-₹5 Cr	-₹5 Cr	₹3 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr
₹0	₹0	₹0	₹0	₹42 L	₹1 Cr	₹22 L	₹0	₹0	₹0	₹4 Cr	₹4 Cr	₹7 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹0	₹0	₹0	₹0
₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹54 L	₹49 L	₹46 L	₹39 L	₹30 L	₹1 Cr	₹0	₹0	₹0	₹0
₹33 Cr	₹29 Cr	₹36 Cr	₹35 Cr	₹31 Cr	₹24 Cr	₹8 Cr	₹3 Cr	₹7 Cr	₹8 Cr	₹71 Cr	₹82 Cr	₹90 Cr	₹99 Cr	₹72 Cr	₹68 Cr	₹128 Cr	₹132 Cr	₹117 Cr	₹88 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹51 Cr	₹51 Cr	₹47 Cr	₹40 Cr	₹32 Cr	₹31 Cr	₹30 Cr	₹35 Cr	₹31 Cr	₹32 Cr	₹35 Cr	₹60 Cr	₹57 Cr	₹52 Cr	₹59 Cr	₹64 Cr	₹55 Cr	₹67 Cr	₹59 Cr	₹59 Cr
₹59 Cr	₹54 Cr	₹50 Cr	₹40 Cr	₹30 Cr	₹39 Cr	₹47 Cr	₹44 Cr	₹30 Cr	₹38 Cr	₹37 Cr	₹17 Cr	₹24 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹4 Cr	₹5 Cr	₹7 Cr	₹7 Cr
₹53 Cr	₹43 Cr	₹47 Cr	₹49 Cr	₹43 Cr	₹57 Cr	₹77 Cr	₹67 Cr	₹64 Cr	₹53 Cr	₹52 Cr	₹54 Cr	₹53 Cr	₹51 Cr	₹75 Cr	₹54 Cr	₹0	₹0	₹0	₹0
₹9 Cr	₹18 Cr	₹18 Cr	₹20 Cr	₹19 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹90 L	₹95 L	₹6 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹8 Cr
₹172 Cr	₹166 Cr	₹162 Cr	₹149 Cr	₹124 Cr	₹128 Cr	₹155 Cr	₹147 Cr	₹125 Cr	₹124 Cr	₹130 Cr	₹136 Cr	₹137 Cr	₹120 Cr	₹150 Cr	₹134 Cr	₹64 Cr	₹76 Cr	₹71 Cr	₹74 Cr
₹604 Cr	₹598 Cr	₹576 Cr	₹524 Cr	₹442 Cr	₹371 Cr	₹345 Cr	₹307 Cr	₹301 Cr	₹284 Cr	₹275 Cr	₹277 Cr	₹284 Cr	₹272 Cr	₹280 Cr	₹293 Cr	₹276 Cr	₹300 Cr	₹273 Cr	₹231 Cr
₹31 Cr	₹26 Cr	₹16 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹11 Cr	₹13 Cr	₹11 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹9 Cr	₹9 Cr	₹18 Cr	₹17 Cr	₹34 Cr	₹23 Cr	₹29 Cr
₹100 Cr	₹83 Cr	₹96 Cr	₹92 Cr	₹79 Cr	₹85 Cr	₹99 Cr	₹82 Cr	₹80 Cr	₹82 Cr	₹128 Cr	₹140 Cr	₹148 Cr	₹155 Cr	₹151 Cr	₹124 Cr	₹124 Cr	₹127 Cr	₹113 Cr	₹84 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹257 Cr	₹253 Cr	₹239 Cr	₹221 Cr	₹192 Cr	₹172 Cr	₹147 Cr	₹146 Cr	₹141 Cr	₹131 Cr	₹212 Cr	₹206 Cr	₹192 Cr	₹185 Cr	₹188 Cr	₹165 Cr	₹162 Cr	₹172 Cr	₹129 Cr	₹106 Cr
₹90 Cr	₹80 Cr	₹71 Cr	₹59 Cr	₹48 Cr	₹39 Cr	₹31 Cr	₹23 Cr	₹15 Cr	₹7 Cr	₹95 Cr	₹84 Cr	₹71 Cr	₹61 Cr	₹54 Cr	₹47 Cr	₹39 Cr	₹35 Cr	₹28 Cr	₹22 Cr
₹167 Cr	₹172 Cr	₹168 Cr	₹162 Cr	₹144 Cr	₹133 Cr	₹116 Cr	₹123 Cr	₹126 Cr	₹124 Cr	₹117 Cr	₹122 Cr	₹121 Cr	₹124 Cr	₹134 Cr	₹119 Cr	₹123 Cr	₹136 Cr	₹101 Cr	₹85 Cr
₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹8 Cr	₹2 Cr	₹2 Cr	₹9 Cr	₹6 Cr	₹3 Cr	₹12 Cr	₹11 Cr	₹7 Cr	₹17 Cr	₹8 Cr	₹2 Cr	₹6 Cr	₹13 Cr
₹109 Cr	₹95 Cr	₹89 Cr	₹70 Cr	₹56 Cr	₹45 Cr	₹35 Cr	₹27 Cr	₹24 Cr	₹22 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹51 L	₹51 L	₹3 Cr	₹2 Cr	₹7 Cr	₹7 Cr
₹109 Cr	₹95 Cr	₹89 Cr	₹70 Cr	₹56 Cr	₹45 Cr	₹35 Cr	₹27 Cr	₹24 Cr	₹22 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹51 L	₹51 L	₹3 Cr	₹2 Cr	₹7 Cr	₹7 Cr
₹14 Cr	₹13 Cr	₹12 Cr	₹13 Cr	₹7 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹12 Cr	₹13 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹12 Cr	₹0	₹0	₹0	₹0
₹1 Cr	₹1 Cr	₹93 L	₹2 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹70 L	₹28 L	₹58 L	₹27 L	₹45 L	₹2 Cr	₹0	₹0	₹0	₹0
₹293 Cr	₹284 Cr	₹273 Cr	₹249 Cr	₹214 Cr	₹186 Cr	₹165 Cr	₹158 Cr	₹157 Cr	₹160 Cr	₹142 Cr	₹143 Cr	₹149 Cr	₹148 Cr	₹151 Cr	₹150 Cr	₹134 Cr	₹140 Cr	₹114 Cr	₹105 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹81 Cr	₹84 Cr	₹71 Cr	₹69 Cr	₹61 Cr	₹58 Cr	₹55 Cr	₹54 Cr	₹50 Cr	₹48 Cr	₹58 Cr	₹62 Cr	₹66 Cr	₹55 Cr	₹47 Cr	₹46 Cr	₹42 Cr	₹55 Cr	₹44 Cr	₹37 Cr
₹178 Cr	₹177 Cr	₹178 Cr	₹145 Cr	₹101 Cr	₹78 Cr	₹102 Cr	₹73 Cr	₹69 Cr	₹48 Cr	₹48 Cr	₹46 Cr	₹40 Cr	₹32 Cr	₹48 Cr	₹67 Cr	₹57 Cr	₹63 Cr	₹70 Cr	₹57 Cr
₹9 Cr	₹13 Cr	₹19 Cr	₹19 Cr	₹26 Cr	₹25 Cr	₹5 Cr	₹3 Cr	₹7 Cr	₹9 Cr	₹14 Cr	₹9 Cr	₹7 Cr	₹12 Cr	₹7 Cr	₹6 Cr	₹15 Cr	₹14 Cr	₹22 Cr	₹16 Cr
₹6 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹42 L	₹9 L	₹82 L	₹75 L
₹36 Cr	₹33 Cr	₹27 Cr	₹35 Cr	₹34 Cr	₹19 Cr	₹12 Cr	₹14 Cr	₹13 Cr	₹13 Cr	₹11 Cr	₹16 Cr	₹21 Cr	₹23 Cr	₹26 Cr	₹23 Cr	₹27 Cr	₹28 Cr	₹22 Cr	₹16 Cr
₹311 Cr	₹314 Cr	₹302 Cr	₹275 Cr	₹228 Cr	₹185 Cr	₹180 Cr	₹150 Cr	₹143 Cr	₹124 Cr	₹133 Cr	₹133 Cr	₹134 Cr	₹124 Cr	₹129 Cr	₹144 Cr	₹142 Cr	₹160 Cr	₹159 Cr	₹126 Cr
₹139 Cr	₹148 Cr	₹140 Cr	₹125 Cr	₹105 Cr	₹57 Cr	₹26 Cr	₹3 Cr	₹18 Cr	₹23 L	₹3 Cr	-₹2 Cr	-₹3 Cr	₹4 Cr	-₹21 Cr	₹9 Cr	₹78 Cr	₹84 Cr	₹88 Cr	₹52 Cr
₹604 Cr	₹598 Cr	₹576 Cr	₹524 Cr	₹442 Cr	₹371 Cr	₹345 Cr	₹307 Cr	₹301 Cr	₹284 Cr	₹275 Cr	₹277 Cr	₹284 Cr	₹272 Cr	₹280 Cr	₹293 Cr	₹276 Cr	₹300 Cr	₹273 Cr	₹231 Cr
₹43	₹44	₹41	₹369	₹312	₹237	₹199	₹172	₹183	₹166	₹87	₹70	₹67	₹64	₹73	₹114	₹104	₹83	₹105	₹85
₹43	₹44	₹41	₹37	₹31	₹24	₹20	₹172	₹183	₹166	₹87	₹70	₹67	₹64	₹73	₹114	₹104	₹83	₹105	₹85

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹2 Cr	₹40 Cr	₹53 Cr	₹73 Cr	₹95 Cr	₹41 Cr	₹27 Cr	-₹13 Cr	₹11 Cr	₹18 Cr	₹31 Cr	₹20 Cr	₹20 Cr	₹11 Cr	-₹18 Cr	₹21 Cr	₹29 Cr	₹3 Cr	₹29 Cr	₹16 Cr
₹3 Cr	₹11 Cr	-₹1 Cr	₹3 L	-₹24 L	₹8 Cr	₹9 Cr	₹17 Cr	₹15 Cr	₹16 Cr	₹10 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹4 Cr	₹3 Cr
-₹2 Cr	-₹5 Cr	-₹21 Cr	-₹40 Cr	-₹43 Cr	₹8 Cr	-₹36 Cr	₹7 Cr	-₹19 Cr	-₹35 Cr	-₹57 L	₹2 Cr	-₹3 Cr	₹3 Cr	₹11 Cr	-₹12 Cr	-₹21 Cr	-₹2 Cr	-₹29 Cr	-₹6 Cr
₹3 Cr	₹45 Cr	₹31 Cr	₹32 Cr	₹52 Cr	₹57 Cr	₹57 L	₹11 Cr	₹7 Cr	-₹2 Cr	₹40 Cr	₹33 Cr	₹25 Cr	₹22 Cr	₹57 L	₹15 Cr	₹14 Cr	₹8 Cr	₹5 Cr	₹13 Cr
-₹3 Cr	₹35 Cr	₹22 Cr	₹16 Cr	₹34 Cr	₹57 Cr	₹33 L	₹11 Cr	₹8 Cr	-₹2 Cr	₹26 Cr	₹19 Cr	₹8 Cr	₹4 Cr	-₹14 Cr	₹4 Cr	₹3 Cr	-₹9 Cr	-₹7 Cr	₹7 Cr
-₹3 Cr	-₹12 Cr	-₹16 Cr	-₹24 Cr	-₹16 Cr	-₹16 Cr	-₹5 Cr	-₹4 Cr	-₹4 L	-₹4 Cr	-₹7 Cr	-₹6 Cr	-₹7 Cr	-₹5 Cr	-₹12 Cr	-₹9 Cr	₹8 Cr	-₹6 Cr	-₹14 Cr	-₹11 Cr
₹4 Cr	-₹26 Cr	-₹9 Cr	₹14 L	-₹18 Cr	-₹26 Cr	₹7 Cr	-₹10 Cr	-₹9 Cr	₹5 Cr	-₹13 Cr	-₹18 Cr	₹2 Cr	₹29 Cr	₹5 Cr	-₹2 Cr	-₹15 Cr	₹1 Cr	₹35 Cr	₹11 Cr
-₹2 Cr	-₹3 Cr	-₹3 Cr	-₹8 Cr	₹1 Cr	₹16 Cr	₹2 Cr	-₹3 Cr	-₹1 Cr	-₹38 L	₹5 Cr	-₹5 Cr	₹4 Cr	₹29 Cr	-₹21 Cr	-₹7 Cr	-₹3 Cr	-₹13 Cr	₹13 Cr	₹7 Cr
₹7 Cr	₹10 Cr	₹13 Cr	₹20 Cr	₹19 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹6 Cr	₹6 Cr	-₹40 Cr	-₹35 Cr	-₹38 Cr	-₹67 Cr	-₹46 Cr	-₹39 Cr	-₹36 Cr	-₹23 Cr	₹9 Cr	-₹20 Cr
₹5 Cr	₹7 Cr	₹10 Cr	₹13 Cr	₹20 Cr	₹19 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹6 Cr	-₹34 Cr	-₹40 Cr	-₹35 Cr	-₹38 Cr	-₹67 Cr	-₹46 Cr	-₹39 Cr	-₹36 Cr	₹23 Cr	-₹13 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Themis Medicare Share Price

100.70+0.97 (+0.97%)

-19.51% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Themis Medicare Share Price

100.70+0.97 (+0.97%)

-19.51% past 1 Year

Shareholding summary

Promoters

67.11%

FII

0.01%

DII

0.01%

Others

32.87%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
67.11%	67.11%	67.11%	67.11%	67.15%	67.15%
0.01%	0.01%	0.11%	0.05%	0.06%	0.09%
0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
32.87%	32.87%	32.77%	32.83%	32.78%	32.75%

Bulk & block deals

Name

Graviton Research Capital Llp

Nk Securities Research Private Limited

Graviton Research Capital Llp

Nk Securities Research Private Limited

Tejas Tradefin Llp

Anuj Anantrai Sheth

Gagandeep Credit Capital Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
09 Oct 2025	Purchase	9.32 Cr	₹141.32	6.59 L	Bulk	0.716379	NSE
09 Oct 2025	Purchase	9.71 Cr	₹141.61	6.86 L	Bulk	0.745272	NSE
09 Oct 2025	Sell	9.34 Cr	₹141.63	6.59 L	Bulk	0.716379	NSE
09 Oct 2025	Sell	9.72 Cr	₹141.72	6.86 L	Bulk	0.745272	NSE
02 Jun 2021	Purchase	5.30 Cr	₹735.76	72.01 K	Bulk	0.078186	NSE
12 Mar 2013	Purchase	67.78 L	₹60.25	1.12 L	Bulk	0.12215	BSE
12 Mar 2013	Sell	67.78 L	₹60.25	1.12 L	Bulk	0.12215	BSE

Insider trading & SAST

Client name

Vividhmargi Investments Private Limited

Vividhmargi Trust

Vividhmargi Investments Pvt Ltd

Vividhmargi Investments Private Limited

Vividhmargi Investments Private Ltd

Vividhmargi Investments Pvt Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
30 Oct 2026	Promoter	Pledge	—	—	—	15 L	22 Oct 2026	Creation	45,00,000	SAST	Reg31	—
30 Oct 2026	Promoter	Pledge	—	—	—	25 L	27 Oct 2026	Creation	70,00,000	SAST	Reg31	—
07 Aug 2026	Promoter	Pledge	—	—	—	30 L	30 Jul 2026	Creation	30,00,000	SAST	Reg31	—
09 Jul 2026	Promoter	Pledge	—	—	—	2.53 Cr	29 Jun 2026	Creation	2,53,17,620	SAST	Reg31	—
11 May 2026	Promoter	Acquisition	10.75	26.52	—	99.01 L	24 Mar 2026	Scheme Of Amalgamation	2,44,29,460	SAST	29(2)	—
24 Dec 2024	Promoter	Pledge	—	—	—	1.30 Cr	30 Dec 2023	Release	15,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	15 L	28 Dec 2023	Release	1,30,28,420	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	15 L	29 Dec 2023	Creation	1,45,28,420	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	15 L	29 Dec 2023	Creation	1,45,28,420	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	1.30 Cr	30 Dec 2023	Release	15,00,000	SAST	Reg31	—

Themis Medicare Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Themis Medicare Share Price

Themis Medicare Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Themis Medicare Share Price

Themis Medicare Share Price

Oscillators

Moving averages

Themis Medicare Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Themis Medicare Share Price

Corporate Actions

Company details

Themis Medicare Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Themis Medicare Share Price

News

Themis Medicare reports Q1 net loss on one time share sale gain

Themis Medicare reports wider Q1 EBITDA loss year on year

Themis Medicare promoter group releases pledge of 15 lakh shares on July 8

Themis Medicare reports Profit after tax of 1.97 Crores, in the March 2026 quarter

Themis Medicare informs about compliance certificate

Themis Medicare Q3FY26 Results: EBITDA Growth Amid Revenue Decline

Themis Medicare Q3 FY26 Results: Net Profit Surges 1,920% YoY to Rs 10.10 Crores

Themis Medicare reports Profit after tax of 4.58 Crores, in the December 2025 quarter

Themis Medicare Q2 revenue plunges year-on-year to Rs 77.9 crores amid sector volatility

Themis Medicare reports Profit after tax of Rs -5.35 Crores, in the September 2025 quarter

Themis Medicare Q2 FY26: Reports net loss of Rs 5.40 crores versus Rs 9.90 crores profit YoY.

Themis Medicare Q2 FY26 reports EBITDA loss versus previous year gain; substantial negative swing

Themis Medicare informs about updates

Themis Medicare - Quaterly Results

Themis Medicare - Quaterly Results

Themis Medicare reports Profit after tax of Rs -15.37 Crores, in the June 2025 quarter

Themis Medicare: Q1 Ebitda Loss 10.10 Crores Rupees Vs Gain 29.20 Crores (Yoy)

Themis Medicare: Q1 Cons Net Loss 14.20 Crores Rupees Vs Profit 24.70 Crores (Yoy) || Q1 Revenue 97.60 Crores Rupees Vs 130.00 Crores (Yoy)

Themis Medicare: Gujarat Themis Biosyn Announces Withdrawal Of Proposed Amalgamation Scheme With Co ??

Themis Medicare: Q4 Revenue Decrease Of 26.70% From Previous

Themis Medicare Ltd Share Price Today

Themis Medicare Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator